<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-01838993</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-14T02:53:49+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy</title>
            <author role="aut">
              <persName>
                <forename type="first">L.</forename>
                <surname>Laforest</surname>
              </persName>
              <email type="md5">74b9efac4237c413190ec3e68da9e653</email>
              <email type="domain">univ-lyon1.fr</email>
              <idno type="idhal" notation="string">laurent-laforest</idno>
              <idno type="idhal" notation="numeric">20412</idno>
              <idno type="halauthorid" notation="string">2284-20412</idno>
              <idno type="IDREF">https://www.idref.fr/095161066</idno>
              <affiliation ref="#struct-421734"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Philippe</forename>
                <surname>Moulin</surname>
              </persName>
              <email type="md5">4e0dca727cc156243498d59b4a4df153</email>
              <email type="domain">chu-lyon.fr</email>
              <idno type="idhal" notation="numeric">1538957</idno>
              <idno type="halauthorid" notation="string">21945-1538957</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-8344-7814</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Thierry</forename>
                <surname>Souchet</surname>
              </persName>
              <idno type="halauthorid">1398313-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Cécile</forename>
                <surname>Ritleng</surname>
              </persName>
              <idno type="halauthorid">1398314-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Gaëlle</forename>
                <surname>Desamericq</surname>
              </persName>
              <idno type="halauthorid">1398315-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Philippe</forename>
                <surname>Le Jeunne</surname>
              </persName>
              <idno type="halauthorid">1398316-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Marie-Sophie</forename>
                <surname>Schwalm</surname>
              </persName>
              <idno type="halauthorid">1398317-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Alexia</forename>
                <surname>Kieffer</surname>
              </persName>
              <idno type="halauthorid">229079-0</idno>
              <affiliation ref="#struct-3065"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Eric</forename>
                <surname>van Ganse</surname>
              </persName>
              <idno type="idhal" notation="numeric">792160</idno>
              <idno type="halauthorid" notation="string">1398275-792160</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7463-9187</idno>
              <idno type="IDREF">https://www.idref.fr/095161139</idno>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Christelle</forename>
                <surname>Cheval</surname>
              </persName>
              <email type="md5">7a04b984c0913330e8e8f067bb704ed2</email>
              <email type="domain">univ-lyon1.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2018-07-13 16:45:59</date>
              <date type="whenModified">2025-11-20 17:09:01</date>
              <date type="whenReleased">2018-07-13 16:45:59</date>
              <date type="whenProduced">2008-08</date>
              <ref type="externalLink" target="https://api.istex.fr/ark:/67375/6H6-X0J5321F-Z/fulltext.pdf?sid=hal"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="318410">
                <persName>
                  <forename>Christelle</forename>
                  <surname>Cheval</surname>
                </persName>
                <email type="md5">7a04b984c0913330e8e8f067bb704ed2</email>
                <email type="domain">univ-lyon1.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-01838993</idno>
            <idno type="halUri">https://univ-lyon1.hal.science/hal-01838993</idno>
            <idno type="halBibtex">laforest:hal-01838993</idno>
            <idno type="halRefHtml">&lt;i&gt;Atherosclerosis&lt;/i&gt;, 2008, 199 (2), pp.368--377. &lt;a target="_blank" href="https://dx.doi.org/10.1016/j.atherosclerosis.2007.11.033"&gt;&amp;#x27E8;10.1016/j.atherosclerosis.2007.11.033&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Atherosclerosis, 2008, 199 (2), pp.368--377. &amp;#x27E8;10.1016/j.atherosclerosis.2007.11.033&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UPMC" corresp="SORBONNE-UNIVERSITE">Université Pierre et Marie Curie</idno>
            <idno type="stamp" n="UNIV-LYON1">Université Claude Bernard - Lyon I</idno>
            <idno type="stamp" n="SANTE_PUB_INSERM" corresp="INSERM">Santé Publique à l'Inserm</idno>
            <idno type="stamp" n="SORBONNE-UNIVERSITE">Sorbonne Université</idno>
            <idno type="stamp" n="UDL">UDL</idno>
            <idno type="stamp" n="UNIV-LYON">Université de Lyon</idno>
            <idno type="stamp" n="ALLIANCE-SU"> Alliance Sorbonne Université</idno>
            <idno type="stamp" n="RESHAPE" corresp="UNIV-LYON1">Unité U1290 RESHAPE (RESearch on HealthcAre PErformance)</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy</title>
                <author role="aut">
                  <persName>
                    <forename type="first">L.</forename>
                    <surname>Laforest</surname>
                  </persName>
                  <email type="md5">74b9efac4237c413190ec3e68da9e653</email>
                  <email type="domain">univ-lyon1.fr</email>
                  <idno type="idhal" notation="string">laurent-laforest</idno>
                  <idno type="idhal" notation="numeric">20412</idno>
                  <idno type="halauthorid" notation="string">2284-20412</idno>
                  <idno type="IDREF">https://www.idref.fr/095161066</idno>
                  <affiliation ref="#struct-421734"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Philippe</forename>
                    <surname>Moulin</surname>
                  </persName>
                  <email type="md5">4e0dca727cc156243498d59b4a4df153</email>
                  <email type="domain">chu-lyon.fr</email>
                  <idno type="idhal" notation="numeric">1538957</idno>
                  <idno type="halauthorid" notation="string">21945-1538957</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-8344-7814</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Thierry</forename>
                    <surname>Souchet</surname>
                  </persName>
                  <idno type="halauthorid">1398313-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Cécile</forename>
                    <surname>Ritleng</surname>
                  </persName>
                  <idno type="halauthorid">1398314-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Gaëlle</forename>
                    <surname>Desamericq</surname>
                  </persName>
                  <idno type="halauthorid">1398315-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Philippe</forename>
                    <surname>Le Jeunne</surname>
                  </persName>
                  <idno type="halauthorid">1398316-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Marie-Sophie</forename>
                    <surname>Schwalm</surname>
                  </persName>
                  <idno type="halauthorid">1398317-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Alexia</forename>
                    <surname>Kieffer</surname>
                  </persName>
                  <idno type="halauthorid">229079-0</idno>
                  <affiliation ref="#struct-3065"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Eric</forename>
                    <surname>van Ganse</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">792160</idno>
                  <idno type="halauthorid" notation="string">1398275-792160</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7463-9187</idno>
                  <idno type="IDREF">https://www.idref.fr/095161139</idno>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="INCOMING">128591</idno>
                <title level="j">Atherosclerosis</title>
                <imprint>
                  <biblScope unit="volume">199</biblScope>
                  <biblScope unit="issue">2</biblScope>
                  <biblScope unit="pp">368--377</biblScope>
                  <date type="datePub">2008-08</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1016/j.atherosclerosis.2007.11.033</idno>
              <idno type="pubmed">18191135</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en"> Monounsaturated</term>
                <term xml:lang="en">Female</term>
                <term xml:lang="en"> Humans</term>
                <term xml:lang="en"> Male</term>
                <term xml:lang="en"> Aged</term>
                <term xml:lang="en"> Middle Aged</term>
                <term xml:lang="en"> Risk Factors</term>
                <term xml:lang="en"> Treatment Outcome</term>
                <term xml:lang="en"> Cholesterol</term>
                <term xml:lang="en"> Sulfonamides</term>
                <term xml:lang="en"> Statin</term>
                <term xml:lang="en"> Pravastatin</term>
                <term xml:lang="en"> Hydroxymethylglutaryl-CoA Reductase Inhibitors</term>
                <term xml:lang="en"> Lipid lowering therapy</term>
                <term xml:lang="en"> LDL-cholesterol</term>
                <term xml:lang="en"> LDL</term>
                <term xml:lang="en"> Fluorobenzenes</term>
                <term xml:lang="en"> Dyslipidemia</term>
                <term xml:lang="en"> Cardiovascular System</term>
                <term xml:lang="en"> Cardiovascular risk</term>
                <term xml:lang="en"> Anticholesteremic Agents</term>
                <term xml:lang="en"> Fatty Acids</term>
                <term xml:lang="en"> Lipids</term>
                <term xml:lang="en"> Indoles</term>
                <term xml:lang="en"> Pyrimidines</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.spee">Life Sciences [q-bio]/Santé publique et épidémiologie</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BACKGROUND: LDL-cholesterol therapeutic objectives attainment under lipid lowering therapy remains inadequate. The correlates of LDL-cholesterol therapeutic objective attainment have not been thoroughly explored in an observational setting. METHODS: Patients under lipid lowering therapy and managed by general practitioners were included. LDL-cholesterol therapeutic objective was defined according to the number of cardiovascular risk factors associated with dyslipidemia (AFSSAPS-2005 guidelines). RESULTS: Most of the 2727 patients (mean age: 64.7+/-11.0) received a statin (70.0%) or a fibrate (24.3%) in monotherapy. 58.5% of patients at high cardiovascular risk did not reach therapeutic objective. Compared to simvastatin, patients receiving fibrates were less likely to be at therapeutic objective (OR=0.38, 95% CI=[0.26-0.54]). So were patients receiving fluvastatin (OR=0.41, IC95%=[0.26-0.64]) or pravastatin (OR=0.49, IC95%=[0.35-0.70]) at the dosages used by GPs. No significant difference appeared with atorvastatin (OR=0.99, 95% CI=[0.71-1.39]) or rosuvastatin (OR=1.25, CI95%=[0.77-2.02]). Patients with LDL-cholesterol levels\\textless0.7 g/L tended to be prescribed high doses of lipid lowering therapy. CONCLUSIONS: In real conditions of lipid lowering therapy use, LDL-cholesterol therapeutic objective attainment was inadequate in high-risk patients, and TO differences were observed between drugs at prescribed doses.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-421734" status="OLD">
          <idno type="IdRef">203652991</idno>
          <idno type="RNSR">201622306F</idno>
          <orgName>Health Service and Performance Research</orgName>
          <orgName type="acronym">HESPER</orgName>
          <date type="start">2016-01-01</date>
          <date type="end">2020-12-31</date>
          <desc>
            <address>
              <addrLine>Site Lacassagne 162 Avenue Lacassagne69424 Lyon 3e</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.hesper.fr</ref>
          </desc>
          <listRelation>
            <relation name="EA7425" active="#struct-194495" type="direct"/>
            <relation active="#struct-301088" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-3065" status="OLD">
          <orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
          <orgName type="acronym">ESIM</orgName>
          <desc>
            <address>
              <addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u707.jussieu.fr</ref>
          </desc>
          <listRelation>
            <relation active="#struct-93591" type="direct"/>
            <relation name="U707" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-194495" status="VALID">
          <idno type="IdRef">026402823</idno>
          <idno type="ISNI">0000000121686185</idno>
          <idno type="ROR">https://ror.org/029brtt94</idno>
          <orgName>Université Claude Bernard Lyon 1</orgName>
          <orgName type="acronym">UCBL</orgName>
          <desc>
            <address>
              <addrLine>43, boulevard du 11 novembre 1918, 69622 Villeurbanne cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-lyon1.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301088" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-301088" status="VALID">
          <idno type="ROR">https://ror.org/01rk35k63</idno>
          <orgName>Université de Lyon</orgName>
          <desc>
            <address>
              <addrLine>92 rue Pasteur - CS 30122, 69361 Lyon Cedex 07</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.universite-lyon.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-93591" status="OLD">
          <idno type="ROR">https://ror.org/02en5vm52</idno>
          <orgName>Université Pierre et Marie Curie - Paris 6</orgName>
          <orgName type="acronym">UPMC</orgName>
          <date type="end">2017-12-31</date>
          <desc>
            <address>
              <addrLine>4 place Jussieu - 75005 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.upmc.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>